Cargando…
One-Year Outcomes With Venovenous Extracorporeal Membrane Oxygenation Support for Severe COVID-19
BACKGROUND: Severe coronavirus disease 2019 (COVID-19) can cause acute respiratory failure requiring mechanical ventilation. Venovenous (VV) extracorporeal membrane oxygenation (ECMO) has been used in patients in whom conventional mechanical ventilatory support has failed. To date, published data ha...
Autores principales: | Smith, Deane E., Chang, Stephanie H., Geraci, Travis C., James, Les, Kon, Zachary N., Carillo, Julius A., Alimi, Marjan, Williams, David, Scheinerman, Joshua A., Cerfolio, Robert J., Grossi, Eugene A., Moazami, Nader, Galloway, Aubrey C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by The Society of Thoracic Surgeons
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907014/ https://www.ncbi.nlm.nih.gov/pubmed/35282865 http://dx.doi.org/10.1016/j.athoracsur.2022.01.003 |
Ejemplares similares
-
Extracorporeal Membrane Oxygenation Support in Severe COVID-19
por: Kon, Zachary N., et al.
Publicado: (2021) -
Extracorporeal Membrane Oxygenation Impact on Host Transcriptomic Response in Severe Coronavirus
por: Smith, Deane E., et al.
Publicado: (2023) -
Efficacy of proning in acute respiratory distress syndrome on extracorporeal membrane oxygenation
por: Chang, Stephanie H., et al.
Publicado: (2022) -
Logistics for expanding heart transplantation from donation after circulatory death using normothermic regional perfusion
por: Moazami, Nader, et al.
Publicado: (2022) -
Extended Robotic Pulmonary Resections
por: Scheinerman, Joshua A., et al.
Publicado: (2021)